Global Oncology Academy

Investigating a Therapy for Brain Metastases: A Growing Problem

ReachMD Healthcare Image

What were the findings of pembrolizumab in the treatment of patients with brain metastases? Tune in to uncover the data.

  • Overview

    Brain metastases are the most common type of brain tumor, and unfortunately, prognosis is still limited and can range from a few months to a few years. However, the next-step approaches look promising for improving patient outcomes. Dive in with Dr. Charles Turck as he speaks with Dr. Priscilla Brastianos, Associate Professor of Medicine at Harvard Medical School and the Director of the Central Nervous System Metastasis Center at Massachusetts General Hospital.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free